Patient Portal

Erik Richard Dubberke, MD

Associate Professor, Medicine
Division of Infectious Diseases

Specialty Areas

Infectious Diseases
Oncology

Board Certifications

Internal Medicine
Infectious Diseases

Hospital Affiliations

Barnes-Jewish Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients,  infections in cancer patients, fecal transplantation

  • Location(s)
  • Education
  • Publication & Research

Location(s)

Location(s)

Taylor Ave. Building Extension

620 South Taylor Ave.
Suite 100
St. Louis, MO 63110

Office Phone: 314-747-1206
Fax: 314-222-6252

Education

Education

Residency: Washington University School of Medicine, St. Louis, Missouri 2002
Medical Degree: University of Illinois at Chicago College of Medicine, Rockford, Illinois 1999
B.A.: Augustana College, Rock Island, Illinois 1995

Publication & Research

Publication & Research

Quantitative Results of a National Intervention to Prevent Clostridioides difficile Infection: A Pre-Post Observational Study.
Dubberke ER, Rohde JM, Saint S, Jones K, Snyder A, Rolle AJ, Chopra V
Ann Intern Med. 2019 Oct 1; 171(7_Supplement)S52-S58. doi: 10.7326/M18-3545.

PMID:
    31569233
    [PubMed - in process]
Related citations


A Tiered Approach for Preventing Clostridioides difficile Infection.
Rohde JM, Jones K, Padron N, Olmsted RN, Chopra V, Dubberke ER
Ann Intern Med. 2019 Oct 1; 171(7_Supplement)S45-S51. doi: 10.7326/M18-3444.

PMID:
    31569223
    [PubMed - in process]
Related citations


Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centred prospective cohort study.
Honda H, Kato H, Olsen MA, Reske KA, Senoh M, Fukuda T, Tagashira Y, Mahe C, Dubberke ER, Clostridioides difficile infection Japan study group.
J Hosp Infect. 2019 Sep 19; pii: S0195-6701(19)30400-1. doi: 10.1016/j.jhin.2019.09.012.

PMID:
    31542458
    [PubMed - as supplied by publisher]
Related citations


Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.
Thänert R, Reske KA, Hink T, Wallace MA, Wang B, Schwartz DJ, Seiler S, Cass C, Burnham CA, Dubberke ER, Kwon JH, Dantas G
MBio. 2019 Aug 27; 10(4)pii: e01977-19. doi: 10.1128/mBio.01977-19.

PMID:
    31455657
    [PubMed - in process]
Related citations


Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.
Robinson JI, Weir WH, Crowley JR, Hink T, Reske KA, Kwon JH, Burnham CD, Dubberke ER, Mucha PJ, Henderson JP
J Clin Invest. 2019 Aug 12; 1303792-3806. doi: 10.1172/JCI126905.

PMID:
    31403473
    [PubMed - in process]
Related citations


Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.
Wilcox MH, Rahav G, Dubberke ER, Gabryelski L, Davies K, Berry C, Eves K, Ellison MC, Guris D, Dorr MB
Open Forum Infect Dis. 2019 Aug 1; 6(8)pii: ofz293. doi: 10.1093/ofid/ofz293.

PMID:
    31375837
    [PubMed]
Related citations


A national survey of testing and management of asymptomatic carriage of C. difficile.
Kutty PK, Beekmann SE, Sinkowitz-Cochran RL, Dubberke ER, Kuhar DT, McDonald LC, Polgreen PM
Infect Control Hosp Epidemiol. 2019 Jul; 40(7)801-803. doi: 10.1017/ice.2019.109.

PMID:
    31106723
    [PubMed - in process]
Related citations


Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
Mullane KM, Dubberke ER, AST ID Community of Practice.
Clin Transplant. 2019 Sep; 33(9)e13564. doi: 10.1111/ctr.13564.

PMID:
    31002420
    [PubMed - in process]
Related citations


Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient.
Pande A, Dubberke ER
Infect Dis Clin North Am. 2019 Jun; 33(2)485-500. doi: 10.1016/j.idc.2019.02.008.

PMID:
    30940460
    [PubMed - in process]
Related citations


Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
Kato H, Senoh M, Honda H, Fukuda T, Tagashira Y, Horiuchi H, Chiba H, Suzuki D, Hosokawa N, Kitazono H, Norisue Y, Kume H, Mori N, Morikawa H, Kashiwagura S, Higuchi A, Kato H, Nakamura M, Ishiguro S, Morita S, Ishikawa H, Watanabe T, Kojima K, Yokomaku I, Bando T, Toimoto K, Moriya K, Kasahara K, Kitada S, Ogawa J, Saito H, Tominaga H, Shimizu Y, Masumoto F, Tadera K, Yoshida J, Kikuchi T, Yoshikawa I, Watanabe T, Honda M, Yokote K, Toyokawa T, Miyazato H, Nakama M, Mahe C, Reske K, Olsen MA, Dubberke ER
Anaerobe. 2019 Mar 12; pii: S1075-9964(19)30046-0. doi: 10.1016/j.anaerobe.2019.03.007.

PMID:
    30872073
    [PubMed - as supplied by publisher]
Related citations


Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
Bulow C, Langdon A, Hink T, Wallace M, Reske KA, Patel S, Sun X, Seiler S, Jones S, Kwon JH, Burnham CA, Dantas G, Dubberke ER
mSphere. 2018 Nov 21; 3(6)pii: e00588-18. doi: 10.1128/mSphereDirect.00588-18.

PMID:
    30463925
    [PubMed - indexed for MEDLINE]
Related citations


Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.
Basu A, Prabhu VS, Dorr MB, Golan Y, Dubberke ER, Cornely OA, Heimann SM, Pedley A, Xu R, Hanson ME, Marcella S
Open Forum Infect Dis. 2018 Nov; 5(11)ofy218. doi: 10.1093/ofid/ofy218.

PMID:
    30460321
    [PubMed]
Related citations


Clostridium difficile infection increases acute and chronic morbidity and mortality.
Olsen MA, Stwalley D, Demont C, Dubberke ER
Infect Control Hosp Epidemiol. 2019 Jan; 40(1)65-71. doi: 10.1017/ice.2018.280.

PMID:
    30409240
    [PubMed - in process]
Related citations


Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
Dubberke ER, Reske KA, Hink T, Kwon JH, Cass C, Bongu J, Burnham CD, Henderson JP
Infect Control Hosp Epidemiol. 2018 Nov; 39(11)1330-1333. doi: 10.1017/ice.2018.225.

PMID:
    30226126
    [PubMed - indexed for MEDLINE]
Related citations


An Assessment of Inappropriate Antibiotic Use and Guideline Adherence for Uncomplicated Urinary Tract Infections.
Durkin MJ, Keller M, Butler AM, Kwon JH, Dubberke ER, Miller AC, Polgreen PM, Olsen MA
Open Forum Infect Dis. 2018 Sep; 5(9)ofy198. doi: 10.1093/ofid/ofy198.

PMID:
    30191156
    [PubMed]
Related citations


Reply to Million et al.
Dubberke ER, Blount K, Gerding DN
Clin Infect Dis. 2018 Nov 13; 67(11)1799-1800. doi: 10.1093/cid/ciy460.

PMID:
    30084881
    [PubMed - indexed for MEDLINE]
Related citations


Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
Prabhu VS, Cornely OA, Golan Y, Dubberke ER, Heimann SM, Hanson ME, Liao J, Pedley A, Dorr MB, Marcella S
Clin Infect Dis. 2017 Oct 1; 65(7)1218-1221. doi: 10.1093/cid/cix523.

PMID:
    30060024
    [PubMed - indexed for MEDLINE]
Related citations


Increasing Age Has Limited Impact on Risk of <i>Clostridium difficile</i> Infection in an Elderly Population.
Olsen MA, Stwalley D, Demont C, Dubberke ER
Open Forum Infect Dis. 2018 Jul; 5(7)ofy160. doi: 10.1093/ofid/ofy160.

PMID:
    30046643
    [PubMed]
Related citations


A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.
Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS
Clin Infect Dis. 2019 Jan 7; 68(2)196-203. doi: 10.1093/cid/ciy484.

PMID:
    29893798
    [PubMed - in process]
Related citations


Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
Dubberke ER, Lee CH, Orenstein R, Khanna S, Hecht G, Gerding DN
Clin Infect Dis. 2018 Sep 28; 67(8)1198-1204. doi: 10.1093/cid/ciy259.

PMID:
    29617739
    [PubMed - in process]
Related citations

Areas of Research Interest

Clostridium-difficile infection, infections in transplant and oncology patients